Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode
Generic Name: hepatitis a nosode, hepatitis b nosode, hepatitis c nosode
Dosage form: LIQUID. Active ingredients: HEPATITIS A VIRUS (17 [hp_C]/mL); HEPATITIS B VIRUS (17 [hp_C]/mL); HEPATITIS C VIRUS (17 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: HEPATITIS A VIRUS (17 [hp_C]/mL); HEPATITIS B VIRUS (17 [hp_C]/mL); HEPATITIS C VIRUS (17 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
0.5% Lidocaine Hcl
0.5% lidocaine hcl
DESCRIPTION Lidocaine Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of lidocaine hydrochloride in water for injection for parenteral administration in various concentrations with characteristics as follows: Multiple-dose vials contain 0.1% of methylparaben added as preservative. May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. The pH is 6.5 (5.0 to 7.0). See HOW SUPPLIED section for various sizes and strengths.
Cerasus Pentas 7x, 11x, 18x, 30x
cerasus pentas 7x, 11x, 18x, 30x
For contitutional treatments based on homeopathic and anthroposophic indications or as directed by your physician.
Sevabertinib
sevabertinib
11 DESCRIPTION HYRNUO tablets contain sevabertinib, a kinase inhibitor. The chemical name of the drug substance is 3-(3-chloro-2-methoxyanilino)-2-{3-[(2S)-1,4-dioxan-2-ylmethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one hydrate. The molecular formula is C 24 H 25 ClN 4 O 5 (anhydrate) and the molecular weight is 484.93 g/mol (anhydrate).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.